Pharmaceutical companies are moving forward to raise funds… Handok’s purpose is ‘Debt Repayment’
There have been continuous actions to raise funds among domestic pharmaceutical companies in Korea. While Hanmi Pharmaceutical recapitalized KRW 100 billion to secure funds for R&D last year, Daewoong Pharmaceutical recently decided to issue company stocks worth of KRW 100 billion to raise funds ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
